Centered for Investm
and Partnerships
Biodesix Builds Beyond 
the Bell in Colorado
When the Biodesix team marked their 
initial public offering’s fifth anniversary, 
the celebration carried intense meaning.
The company went public in October 
2020. Separated due to COVID, the team 
worked nonstop on the complex steps 
required for an IPO from their home 
offices and kitchen tables. They completed 
more than 200 virtual investor meetings. 
When their big day came, Nasdaq’s leg­
endary bell-ringing ceremonies were 
online only. Employees missed out on 
the moment every entrepreneur dreams 
about, stepping onto the podium to ring 
the closing bell.  
Five years later, Nasdaq invited Chief 
Financial Officer Robin Harper Cowie, 
olorado gives investors access to 
companies growing in a market 
with strong academic and research 
institutions, experienced talent, lower 
operating costs, and close connections 
across the ecosystem. Companies here 
benefit from five R-1 universities, 30+ 
federal laboratories, and a life sciences 
community that has raised more than 
$10 billion over the past five years.
That combination helps promising 
companies use capital carefully, 
build trusted partnerships, and 
prepare for larger opportunities. 
For investors, Colorado offers a 
growing pipeline of companies with 
the talent, infrastructure, and disci­
pline to compete nationally.
Leaders Scale with Intention and Capital Efficiency
C
28     2026-27 BIOSCIENCE COLORADO

View this content as a flipbook by clicking here.